This website is intended for healthcare professionals only

Trending Topic

AI generated heart image pink purple and blue
5 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Duchenne muscular dystrophy (DMD) is an X-linked myopathy resulting from inactivating dystrophin mutations that cause progressive muscle breakdown, affecting 1:5,000 live male births globally. Boys with DMD are typically diagnosed at ~4 years of age, lose ambulation as preteens and die of respiratory or heart failure by their third decade. With modern respiratory support, cardiac […]

Search Results

12 Results Found for “semaglutide”

Speciality Filter

Select Specialty or Clinical Area

Clear All
Update Filters
Close Popup
Rame Abu Fanne
Mark CompleteCompleted
BookmarkBookmarked
Coverage from: ESC Highlights
Rami Abu Fanne

At ESC Congress 2026, Dr Rami Abu Fanne (Hillel Yaffe Medical Center and Hadassah Medical Center, The Hebrew University of Jerusalem) presented an analysis exploring whether baseline vitamin D levels were associated with metabolic response to semaglutide in people with type 2 diabetes. The study included 5,300 adults and found that higher baseline vitamin D levels were associated with greater improvements in glycemic control and BMI after 12 months of treatment, although no association was observed with lipid outcomes. Dr Abu Fanne spoke to touchCARDIO about the findings and the questions they raise for future research.

Mark CompleteCompleted
BookmarkBookmarked

New 2026 ESC Guidelines for the management of heart failure introduce major changes to the classification of heart failure and its treatment, with an increased focus on prevention, earlier intervention and timely referral of patients with advanced disease.

Mark CompleteCompleted
BookmarkBookmarked

Dr Arasi Maran explores practical strategies for integrating lifestyle interventions into the management of complex coronary artery disease, including how to prioritise modifiable risk factors, communicate recommendations effectively and support sustained behaviour change. She also discusses the role of imaging, reliable health information and patient-centred approaches to improving adherence.

Mark CompleteCompleted
BookmarkBookmarked

The American Diabetes Association has released its 2026 Standards of Care, reflecting major advances in diabetes and cardiometabolic management. In this Q&A, Dr Robert Gabbay (Joslin Diabetes Center, Boston, MA, USA) discusses expanded roles for GLP-1–based therapies, updated cardiovascular risk targets, and a growing emphasis on integrated, whole-person care with important implications for cardiovascular clinical practice.

Mark CompleteCompleted
BookmarkBookmarked

Epicardial adipose tissue (EAT) is a fat collection directly adjacent to the myocardium and coronary vasculature, lacking any separation and sharing the same circulation.1,2 This anatomy enables direct signalling between EAT and the surrounding tissue, positioning EAT as a central ...

A new era for cardiovascular-kidney-metabolic health: What to know from ObesityWeek®2025
Mark CompleteCompleted
BookmarkBookmarked

ObesityWeek® 2025 highlighted obesity as a chronic, multi-system disease that links cardiovascular, renal, and metabolic health. New data from clinical trials showcased therapies improving weight, blood pressure, and inflammation, signalling a shift toward integrated care where obesity management becomes central to cardiovascular risk reduction.

June 2025 Cardiology Roundup: Approvals, Trials and Trends
Mark CompleteCompleted
BookmarkBookmarked

June was a dynamic month in cardiovascular medicine, marked by notable regulatory approvals and clinical trial progress across several therapeutic areas. Advances in hypertension management, lipid lowering and cardiometabolic care continue to shape the treatment landscape, while evolving data in pulmonary arterial hypertension underscore the importance of ongoing innovation. This month’s roundup highlights the latest developments poised to impact clinical practice and patient outcomes.

Human heart with red cardio pulse line. Creative stylized red heart cardiogram with human heart on black background. Health, cardiology, cardiovascular diseases concept
Mark CompleteCompleted
BookmarkBookmarked

Cardiovascular disease (CVD) is a significant cause of morbidity and mortality in patients with type 2 diabetes mellitus (T2DM). An estimated 60–80% of patients with T2DM die of cardiovascular events.1,2 A bidirectional relationship has been noted between heart failure (HF) ...

Mark CompleteCompleted
BookmarkBookmarked

A new study in the BMJ has analyzed cardiovascular disease (CVD) trends among 22 million UK residents over the last 20 years, revealing both progress and persistent challenges. The research shows a significant decrease in heart attacks and strokes, thanks to better ...

Mark CompleteCompleted
BookmarkBookmarked

Welcome to the summer issue of Heart International. We are excited to present a collection of insightful articles that delve into various aspects of cardiovascular health and related interventions. This issue encompasses a wide array of topics, from novel treatment ...

Heart within chest digital image
Mark CompleteCompleted
BookmarkBookmarked

Glucagon-like peptide 1 (GLP-1) receptor agonists piqued our interest when Marso et al. demonstrated that liraglutide significantly reduced cardiovascular events (CVEs) in persons with type 2 diabetes mellitus (T2DM) who were at a high cardiovascular (CV) risk compared with placebo in ...

Mark CompleteCompleted
BookmarkBookmarked

Atrial fibrillation (AF) is the most common cardiac arrhythmia observed in clinical practice worldwide.1 The incidence of AF is around 0.1% in individuals under 55 years old and 9% in those aged over 80.2 The global prevalence of AF is estimated to be around 44 ...

Load More...
Close Popup